306 results on '"Zaninoni, Anna"'
Search Results
2. Evaluation of the main regulators of systemic iron homeostasis in pyruvate kinase deficiency
3. Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia
4. Evans syndrome in adults: an observational multicenter study
5. Mechanistic ion channel interactions in red cells of patients with Gárdos channelopathy
6. Glycolytic activity and in vitro effect of the pyruvate kinase activator AG‐946 in red blood cells from low‐risk myelodysplastic syndromes patients: A proof‐of‐concept study
7. Recombinant erythropoietin in autoimmune hemolytic anemia with inadequate bone marrow response: a prospective analysis
8. Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization
9. Cytokine polymorphisms in patients with autoimmune hemolytic anemia
10. Immunomodulatory cytokines and clonal dynamics in low‐risk myelodysplastic syndromes patients treated with luspatercept
11. When alpha spectrin null alleles meet low expression alpha spectrin polymorphisms
12. PB1990: GLYCOLYTIC ACTIVITY AND EFFECT OF EX-VIVO TREATMENT WITH THE PYRUVATE KINASE (PK) ACTIVATOR AG-946 IN RED BLOOD CELLS FROM LOW-RISK MYELODYSPLASTIC SYNDROMES PATIENTS: A PROOF-OF-CONCEPT STUDY
13. PB2546: DIAGNOSTIC POWER OF ERYTHROCYTE AND RETICULOCYTE AUTOMATIC PARAMETERS IN THE SCREENING FOR CONGENITAL HEMOLYTIC ANEMIAS
14. P1568: NATURAL HISTORY OF CHRONIC ISOLATED NEUTROPENIA: A SINGLE CENTER OBSERVATIONAL STUDY
15. P1583: TRANSFUSIONS IN AUTOIMMUNE HEMOLYTIC ANEMIA: FREQUENCY AND CLINICAL SIGNIFICANCE OF ALLOIMMUNIZATION
16. Transfusions in autoimmune hemolytic anemias: Frequency and clinical significance of alloimmunization.
17. Reduced 25-OH vitamin D in patients with autoimmune cytopenias, clinical correlations and literature review
18. Overhydrated hereditary stomatocytosis: A rare cause of familiar persistent macrocytosis due to SLC4A1 variants
19. Is chronic neutropenia always a benign disease? Evidences from a 5-year prospective study
20. Glycolytic Activity and in Vitro Effect of the Pyruvate Kinase Activator AG-946 in Red Blood Cells from Low-Risk Myelodysplastic Syndromes Patients: A Proof-of-Concept Study
21. Case report: Transfusion independence and abolition of extravascular hemolysis in a PNH patient treated with pegcetacoplan
22. Evaluation of the Main Regulators of Systemic Iron Homeostasis in Pyruvate Kinase Deficiency
23. Evaluation of Red Blood Cell Metabolism in Patients with Low-Risk Myelodysplastic Syndrome (LR-MDS): A Proof-of-Concept Study
24. Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
25. Effect of primary lesions in cytoskeleton proteins on red cell membrane stability in patients with hereditary spherocytosis
26. Increased prevalence of autoimmune phenomena in myelofibrosis: Relationship with clinical and morphological characteristics, and with immunoregulatory cytokine patterns
27. Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes
28. Low-dose rituximab in adult patients with idiopathic autoimmune hemolytic anemia: clinical efficacy and biologic studies
29. Efficacy and Immunomodulating Properties of Eltrombopag in Aplastic Anemia following Autologous Stem Cell Transplant: Case Report and Review of the Literature
30. Low-Risk Myelodysplastic Syndrome Revisited: Morphological, Autoimmune, and Molecular Features as Predictors of Outcome in a Single Center Experience
31. Changing trends of splenectomy in hereditary spherocytosis: The experience of a reference Centre in the last 40 years
32. Evaluation of the Main Regulators of Systemic Iron Homeostasis in Pyruvate Kinase Deficiency
33. Single Nucleotide Polymorphisms of Cytokine Genes in Warm Autoimmune Hemolytic Anemias: Relationship with Clinical and Hematological Parameters
34. Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectives
35. Detection of red blood cell antibodies in mitogen-stimulated cultures from patients with hereditary spherocytosis
36. Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias
37. Biochemical and Metabolomic Analysis of Glycolytic Activity in Red Blood Cells from Low-Risk Myelodysplastic Syndromes (LR-MDS) Patients and in-Vitro Effect of the Pyruvate Kinase Activator AG-946
38. Comparison of traditional methods and mitogen-stimulated direct antiglobulin test for detection of anti-red blood cell autoimmunity
39. Targeted Next Generation Sequencing and Diagnosis of Congenital Hemolytic Anemias: A Three Years Experience Monocentric Study
40. Evans syndrome in adults:an observational multicenter study
41. The Immunomodulatory Effect and Clinical Efficacy of Daratumumab in a Patient With Cold Agglutinin Disease
42. Circulating extracellular vesicles and cytokines in congenital and acquired hemolytic anemias
43. Sustained response to low-dose rituximab in idiopathic autoimmune hemolytic anemia
44. Red Blood Cell Morphodynamics: A New Potential Marker in High-Risk Patients
45. Low-dose rituximab in autoimmune hemolytic anemia: 10 years after
46. New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
47. Congenital Hemolytic Anemias: Is There a Role for the Immune System?
48. Small Paroxysmal Nocturnal Hemoglobinuria Clones in Autoimmune Hemolytic Anemia: Clinical Implications and Different Cytokine Patterns in Positive and Negative Patients
49. Cytokine modulation of nuclear factor-κB activity in B-chronic lymphocytic leukemia
50. Clinical and Molecular Spectrum of Glucose-6-Phosphate Isomerase Deficiency. Report of 12 New Cases
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.